Anthony Lohmeier

Anthony Lohmeier is a Senior Research Associate at Verve Therapeutics, where employment began in January 2023. Prior roles include Research Scientist at RT MicroDx from June 2022 to December 2022, and Research Associate at Fluent BioSciences Inc. from May 2021 to June 2022, where significant contributions involved the development of an amplicon sequencing assay for detecting circulating tumor DNA. Additionally, Anthony served as a Student Research Assistant at the University of Michigan from September 2019 to May 2020, focusing on the discovery and engineering of CRISPR molecular gene editors. Anthony earned a Bachelor of Science in Biochemistry from the University of Michigan College of Literature, Science, and the Arts during the years 2018 to 2021.